Schizophrenia Research Forum - A Catalyst for Creative Thinking


Shekhar A, Potter WZ, Lightfoot J, Lienemann J, Dubé S, Mallinckrodt C, Bymaster FP, McKinzie DL, Felder CC. Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia. Am J Psychiatry. 2008 Aug ; 165(8):1033-9. Pubmed Abstract

Comments on News and Primary Papers
Comment by:  John Michael Brummer
Submitted 6 September 2008
Posted 6 September 2008
  I recommend the Primary Papers